Literature DB >> 9178466

Protective responses in mice to vaccination with multiply administered cold-adapted influenza vaccine reassortants and wild-type viruses.

J R Romanova1, G A Tannock, G I Alexandrova.   

Abstract

Protective responses to influenza vaccine reassortants derived from the cold-adapted (ca) donor strains A/Leningrad/134/17/57 and B/USSR/60/69 and wild-type epidemic viruses were studied in two strains of mice. Preliminary experiments revealed that, when mixtures of three viruses were inoculated intranasally to mice with 50 microliters containing 10(6) EID50 per 200 microliters (10(5.4) EID50 per mouse), interference between strains did not occur. However, interference with the growth of the influenza reassortant B/60/32/R took place if its concentration in the mixture was reduced to 10(5) (10(4.4) per mouse) or if it was inoculated at 10(6) EID50 (10(5.4) per mouse) in the presence of the influenza reassortant R/34 and two other influenza A epidemic strains; interference was unrelated to serological responses to infection with B/60/32/R. Despite evidence of interference, mice inoculated with the same mixtures in two identical doses, three weeks apart, were able to clear a challenge from each of seven homotypic and heterotypic influenza A and B strains. Heterotypic clearance of influenza A challenge viruses was greater following mixed infection, indicating that common determinants within the surface antigen glycoproteins contributed to immune responses which were broader than could be expected to be induced by parenteral vaccination.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9178466     DOI: 10.1016/s0264-410x(96)00245-9

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  2 in total

1.  Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine.

Authors:  Sarah A Kopecky-Bromberg; Kathryn A Fraser; Natalie Pica; Elena Carnero; Thomas M Moran; Richard W Franck; Moriya Tsuji; Peter Palese
Journal:  Vaccine       Date:  2009-04-23       Impact factor: 3.641

2.  Alternative Strategy for a Quadrivalent Live Attenuated Influenza Virus Vaccine.

Authors:  Zhimin Wan; Stivalis Cardenas Garcia; Jing Liu; Jefferson Santos; Silvia Carnaccini; Ginger Geiger; Lucas Ferreri; Daniela Rajao; Daniel R Perez
Journal:  J Virol       Date:  2018-10-12       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.